|
TANC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13539963489495E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.21819998533113E-09 |
| Normal-vs-Stage2 |
2.764400E-01 |
| Normal-vs-Stage3 |
1.21860000001917E-06 |
| Normal-vs-Stage4 |
1.176640E-03 |
| Stage1-vs-Stage2 |
1.657510E-03 |
| Stage1-vs-Stage3 |
8.009200E-01 |
| Stage1-vs-Stage4 |
5.175600E-01 |
| Stage2-vs-Stage3 |
1.187740E-02 |
| Stage2-vs-Stage4 |
5.254200E-02 |
| Stage3-vs-Stage4 |
6.855600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67149960539348E-10 |
| Normal-vs-AfricanAmerican |
2.163000E-03 |
| Normal-vs-Asian |
2.246800E-04 |
| Caucasian-vs-AfricanAmerican |
6.791800E-01 |
| Caucasian-vs-Asian |
2.625200E-01 |
| AfricanAmerican-vs-Asian |
6.445200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.04800000000349E-06 |
| Normal-vs-Female |
5.34499999815807E-09 |
| Male-vs-Female |
3.618600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.67790001284851E-09 |
| Normal-vs-Age(41-60Yrs) |
5.35680000024463E-07 |
| Normal-vs-Age(61-80Yrs) |
5.337700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.843400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.067700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.597300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.557250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.506800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.700400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.141800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.583200E-01 |
| Classical-VS-Follicular |
1.62458935193399E-12 |
| Classical-VS-Other |
5.662200E-01 |
| Classical-VS-Normal |
2.34257058195908E-14 |
| Tall-VS-Follicular |
3.56719999999866E-05 |
| Tall-VS-Other |
6.788200E-01 |
| Tall-VS-Normal |
2.377800E-04 |
| Follicular-VS-Other |
1.488340E-02 |
| Follicular-VS-Normal |
2.663000E-01 |
| Other-VS-Normal |
1.520160E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.630700E-04 |
| Normal-vs-N1 |
1.048280E-04 |
| N0-vs-N1 |
6.385600E-02 |
|
|
